2023 Form 5500 filing — Ascendis Pharma 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015180339NAL0015215235001) for Ascendis Pharma 401(K) Plan, reported by Ascendis Pharma, Inc. under EIN 26-1969053 and plan number 001. It reports 311 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$27.8MReported net assets$27,769,219
Participants311
Provider compensation$35K2 Schedule C row(s)$34,998
Schedules filedSchedule H, Schedule CLoaded schedules
EFAST2 acknowledgement
20241015180339NAL0015215235001
Plan sponsor
Ascendis Pharma, Inc.
EIN
26-1969053
Plan number
001
Location
Palo Alto, CA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule H · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$27.8M total assets
Net assets$27.8MLiabilities$0
Money in vs. money out
Total income / additions$13.1M
Total expenses$3M
Benefits paid / distributions$3M
Contributions
Employer$2.6M
Participant$5.9M
Full reported line items
Total assets (EOY)
$27,769,219
Total liabilities (EOY)
$0
Net assets (EOY)
$27,769,219
Employer contributions
$2,632,553
Participant contributions
$5,949,288
Total income / additions
$13,119,026
Benefits paid
$2,952,411
Administrative expenses
$34,998
Total expenses
$3,001,031
Net increase / (decrease)
$10,117,995
Schedule C

Reported service provider compensation

Compensation reported on the 2023 filing, ranked by reported total.

  1. 1
    RECORDKEEPER · Direct $34.1K · Indirect $0
  2. 2
    INVESTMENT MGMT · Direct $860

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241015180339NAL0015215235001 cover?
It is the 2023 Form 5500 filing for Ascendis Pharma 401(K) Plan, reported by Ascendis Pharma, Inc. (EIN 26-1969053).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Related Form 5500 pages